Umbra Companies Inc (ZEOX)
Zeo ScientifiX Inc (ZEOX) is a common stock listing on OTC Markets associated with Zeo ScientifiX, Inc., a healthcare company focused on biotechnology. The company is clinical-stage and works on biological therapeutics aimed at degenerative diseases and regenerative medicine. Its lead candidate, Zofin, is an acellular biologic derived from perinatal sources and is being studied in Phase I/II trials for conditions including COVID-19, chronic obstructive pulmonary disease, osteoarthritis, and traumatic brain injury. Zeo ScientifiX also develops Patient Pure X, an autologous biologic intended to support tissue healing and reduce inflammation, along with topical aesthetic products such as ZEO GROWX, ZEO HAIR GROW, and ZEO GROW BOOST. The company maintains a strategic collaboration with Regen Therapy Limited and was incorporated in 2011. It is based in Davie, Florida, and formerly operated under the name Organicell Regenerative Medicine, Inc.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ZEOX
|
Not available
|
Not available
|
Not available
|
Fair
|
0.0%
|
September 22, 2026
|
15.0x
|
1.5x
|
10.816 M
|
9.156 M
|
75.1%
|
47.4%
|
-26.4
|
34.8%
|